Traphagen Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Traphagen Investment Advisors LLC

$868 Million
Q3 2024

A detailed history of Traphagen Investment Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 2,868 shares of GILD stock, worth $257,661. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,868

Previous 3,036 5.53%

Holding current value

$257,661

Previous $208,000 15.38%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$66.59 - $83.99 $11,187 - $14,110	-168 Reduced 5.53%	2,868 $240,000
Q2 2024 Jul 23, 2024	BUY	$63.15 - $72.88 $126 - $145	2 Added 0.07%	3,036 $208,000
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $217,173 - $264,837	3,034 New	3,034 $222 Million
Q4 2023 Jun 17, 2024	SELL	$73.27 - $83.09 $13,335 - $15,122	-182 Reduced 6.0%	2,852 $231 Million
Q3 2023 Jun 17, 2024	SELL	$73.94 - $80.67 $13,531 - $14,762	-183 Reduced 6.03%	2,851 $214 Million
Q2 2023 Jun 17, 2024	SELL	$76.01 - $86.7 $13,909 - $15,866	-183 Reduced 6.03%	2,851 $220 Million
Q4 2022 Jun 17, 2024	SELL	$62.32 - $89.47 $11,466 - $16,462	-184 Reduced 6.06%	2,850 $245 Million
Q3 2022 Jun 17, 2024	BUY	$59.54 - $68.01 $8.02 Million - $9.16 Million	134,661 Added 52.06%	393,346 $17 Billion
Q2 2022 Jun 17, 2024	BUY	$57.72 - $65.01 $14.8 Million - $16.6 Million	255,651 Added 8426.2%	258,685 $11.9 Billion
Q1 2022 Jun 17, 2024	SELL	$57.92 - $72.58 $2.08 Million - $2.6 Million	-35,851 Reduced 25.1%	106,972 $5.33 Billion
Q4 2021 Jun 17, 2024	BUY	$64.88 - $73.64 $9.07 Million - $10.3 Million	139,789 Added 4607.42%	142,823 $7.78 Billion
Q3 2021 Jun 17, 2024	BUY	$67.69 - $73.03 $214,712 - $231,651	3,172 Added 1.98%	163,084 $8.91 Billion
Q2 2021 Jun 17, 2024	BUY	$63.47 - $69.35 $838,882 - $916,598	13,217 Added 9.01%	159,912 $8.81 Billion
Q1 2021 Jun 17, 2024	BUY	$60.0 - $68.46 $8.62 Million - $9.84 Million	143,661 Added 4735.04%	146,695 $7.83 Billion
Q4 2020 Jun 17, 2024	BUY	$56.65 - $64.55 $972,737 - $1.11 Million	17,171 Added 8.87%	210,727 $11.9 Billion
Q3 2020 Jun 17, 2024	BUY	$62.1 - $78.08 $11.8 Million - $14.9 Million	190,577 Added 6397.35%	193,556 $10.7 Billion
Q2 2020 Jun 17, 2024	SELL	$72.34 - $84.0 $3,978 - $4,620	-55 Reduced 1.81%	2,979 $229 Million
Q1 2020 Jun 17, 2024	SELL	$62.63 - $80.22 $3,507 - $4,492	-56 Reduced 1.85%	2,978 $223 Million
Q2 2019 Jun 17, 2024	BUY	$61.87 - $69.38 $2,165 - $2,428	35 Added 1.15%	3,069 $207 Million

Others Institutions Holding GILD

# of Institutions

1,905

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Account

Traphagen Investment Advisors LLC Gilead Sciences, Inc. Transaction History